Investigation of von Willebrand factor in the prevention of bleeding episodes in patients with von Willebrand disease.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 28 Apr 2014
Price : $35 *
At a glance
- Drugs Vonicog alfa (Primary)
- Indications Von Willebrand disease
- Focus Therapeutic Use
- 28 Apr 2014 Study title is not official.
- 28 Apr 2014 New trial record